 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Current Price	$22.28
Prev Close	$21.97
Open	$22.19
Dividend Yield	0.00%
50-Day Moving Average	$19.85
Beta	1.06
Avg. Volume	3.23M
PE Ratio	-23.76

52-Week High	$25.72
52-Week Low	$2.02
Market Capitalization	$2.22B
EPS	-$0.9377
Price to Book	13.18
Revenue Per Employee	N/A
Enterprise Value/EBITDA	-15.74

VKTX Viking Therapeutics Inc

About

Feed

Fundamentals

News